Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells

SARS-CoV-2 receptor-binding domain (RBD) is a major target for the development of diagnostics, vaccines and therapeutics directed against COVID-19. Important efforts have been dedicated to the rapid and efficient production of recombinant RBD proteins for clinical and diagnostic applications. One of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerez, Guillaume, Martinez, Jerome, Steinbrugger, Christophe, Bouanich, Sandra, Dimino, Johanna, Piegay, Corine, Combe, Maxime, Berthier, Franck, Daniel, Soizic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496381/
https://www.ncbi.nlm.nih.gov/pubmed/36139010
http://dx.doi.org/10.3390/biom12091170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496381/
https://www.ncbi.nlm.nih.gov/pubmed/36139010
http://dx.doi.org/10.3390/biom12091170

Ejemplares similares